Zojwalla Naseem 4
4 · Olema Pharmaceuticals, Inc. · Filed Dec 12, 2023
Insider Transaction Report
Form 4
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-12-11$7.02/sh+2,900$20,358→ 46,664 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-11−2,900→ 234,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (2,900 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.